Skip navigation

Ranga Sarangarajan, Ph.D.

Rangaprasad (Ranga) Sarangarajan, Ph.D., is the Senior Vice President and Chief Scientific Officer at BERG who oversees all Research and Development activities including pharmaceutical development & translational sciences strategy development and planning.

Dr. Sarangarajan is the co-inventor of the BERG Interrogative Biology®, a ground-breaking technology intersecting biological constructs and artificial intelligence to identify causal drivers of disease.  He was instrumental in overseeing the development of BERG’s therapeutic pipeline, and continues to provide strategic support in transition of these programs from discovery into various stages of clinical development.  Dr. Sarangarajan is now focused on the next generation R&D innovation in the integration of artificial intelligence/machine learning within biomedical data repositories, Real-World Data (RWD), and Real-World Evidence (RWE) for speeding up identification/validation of targets, tractability, drug discovery and pharmaceutical development.

Dr. Sarangarajan has numerous US and international patents (granted and pending), covering areas of the discovery platform, cancer, neurology, metabolic diseases, diabetes, obesity and diagnostics. He has published extensively and has presented his research at national and international medical and scientific meetings. He co-authored and co-edited Cellular Respiration and Carcinogenesis, a first of its kind treatise on the role of mitochondrial function and metabolic network regulation in the etiology of cancer as it pertains to the seminal observations made by Otto Warburg.

Dr. Sarangarajan has a B.S. in Pharmacy and a graduate degree in Pharmaceutical Sciences from the University of Cincinnati College of Pharmacy with a focus on pharmacology and toxicology. He went on to pursue post-graduate training in genetics, molecular and cell biology for several years prior to joining Massachusetts College of Pharmacy and Health Sciences (now MCPHS University) and served in the capacity of Assistant/Associate Professor. In addition to primary appointments, he has served in several leadership positions in institutional administration and operations, leading teams to achieve successful implementation of group specific goals.